NOCD

Private

Chicago, IllinoisHealthcare & Life Scienceshttps://www.treatmyocd.com

Last Round

Series C

Jan 31, 2023

Est. Valuation

$19.96M

Total Funding Raised

$84M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NOCD is a mental health technology company that offers a telehealth application to help individuals self-treat and monitor their obsessive-compulsive disorder symptoms through guided cognitive-behavioral therapy exercises.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Telemedicine, Patient Engagement

Business Model

B2B2C

Customer Profile

Payment Processing Fee, Freemium

AI Layer

Non-AI

Keywords

OCD treatmentERP therapyExposure and Response Preventiontelehealth platformvirtual mental healthonline therapyOCD appspecialty care platformbehavioral healthin-network therapypeer support communityPTSD treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NOCD Comps

Public and private peers based on sector, stage, and business model.

NOCD comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NOCD Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Jan 31, 2023
Series B	Sep 21, 2021
Series A	Oct 8, 2020
Series A	Oct 1, 2019
Seed	Feb 12, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Ilyas Patanam

Cofounder Chief Growth Officer

Founding Team

Stephen Smith

Co-Founder And Chief Executive Officer

Founding Team

Matthew Thorne

Chief Financial Officer

Executive Team

NOCD Investors

Notable investors and investment history

NOCD investors
Investor	Rounds
Longitude Capital	Series C
Meridian Street Capital	Series A
Chicago Ventures	Series A, Series B
Benz Capital	Series C
Kaiser Permanente Ventures	Series C, Series B
F-Prime Capital	Series C, Series B
7wire Ventures	Series A, Series C

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 28, 2026
Acquired virtual trauma therapy provider Rebound Health.
May 6, 2025
Achieved 90% commercial insurance coverage in the U.S.

View all signals

NOCD Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

NOCD Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NOCD's valuation, stock price, and market status.

Firmographic Details

HeadquartersChicago, Illinois

Employee Range796

Year Founded2014

Last FundingJan 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.